Covid19 Primer

Title	Date	Topic	News	Relevance
Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses Alejandro Fernandez-Montero et al in frontiers in cellular and infection microbiology (5.293) Source crossref_works_2020_03_25	Jan 25, 2023	Placebo-controlled & Randomized	1	0.5
The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19—Results from a pragmatic randomized clinical trial Ikram Din Ujjan et al in frontiers in nutrition (6.576) Source crossref_works_2020_03_25	Jan 18, 2023	Placebo-controlled & Randomized	1	0.3
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial Francesco Di Pierro et al in frontiers in pharmacology (5.81) Source crossref_works_2020_03_25	Jan 13, 2023	Placebo-controlled & Randomized	1	0.5
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial Claudia M. Denkinger et al in nature cancer Source crossref_works_2020_03_25	Dec 29, 2022	Placebo-controlled & Randomized	1	0.8
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine Jenny G. Low et al in npj vaccines (7.344) Source crossref_works_2020_03_25	Dec 13, 2022	Placebo-controlled & Randomized	1	0.2
Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine Jonathan F. Lovell et al in bmc medicine (8.775) Source crossref_works_2020_03_25	Nov 30, 2022	Placebo-controlled & Randomized	1	0.5
Beneficial effects of Chinese patent medicine ZhengQi tablet on treating the mild COVID-19 Bowu Chen et al in None Source crossref_works_2020_03_25	Feb 07, 2023	Placebo-controlled & Randomized	0	0.4
A single center, double blind, randomized, placebo controlled trial of anakinra in adult patients with features of Cytokine Storm Syndrome in COVID-19 Randy Q Cron et al in journal of immunology (5.422) Source crossref_works_2020_03_25	Feb 07, 2023	Placebo-controlled & Randomized	0	0.3
Promoting Hand Hygiene During the COVID-19 Pandemic: Parallel Randomized Trial for the Optimization of the Soapp App Dario Baretta et al in jmir mhealth and uhealth (4.773) Source crossref_works_2020_03_25	Feb 03, 2023	Placebo-controlled & Randomized	0	0.2
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: randomised, active-controlled, observer-blinded, phase 3 trial Joon Young Song et al in medRxiv : the preprint server for health sciences Source crossref_works_2020_03_25 Preprint	Feb 02, 2023	Placebo-controlled & Randomized	0	0.4